Oligosaccharide modification byN-acetylglucosaminyltransferase-V in macrophages are involved in pathogenesis of bleomycin-induced scleroderma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oligosaccharide modification byN-acetylglucosaminyltransferase-V in macrophages are involved in pathogenesis of bleomycin-induced scleroderma
Authors
Keywords
-
Journal
EXPERIMENTAL DERMATOLOGY
Volume 24, Issue 8, Pages 585-590
Publisher
Wiley
Online
2015-04-15
DOI
10.1111/exd.12730
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bleomycin-induced fibrosis in MC1signalling-deficient C57BL/6J-Mc1re/emice further supports a modulating role for melanocortins in collagen synthesis of the skin
- (2014) Markus Böhm et al. EXPERIMENTAL DERMATOLOGY
- Bleomycin inhibits adipogenesis and accelerates fibrosis in the subcutaneous adipose layer through TGF-β1
- (2013) Shiro Ohgo et al. EXPERIMENTAL DERMATOLOGY
- Deciphering the pro-fibrotic phenotype of fibroblasts in systemic sclerosis
- (2013) Christiane Maier et al. EXPERIMENTAL DERMATOLOGY
- Interspecies Comparison of Human and Murine Scleroderma Reveals IL-13 and CCL2 as Disease Subset-Specific Targets
- (2012) Matthew B. Greenblatt et al. AMERICAN JOURNAL OF PATHOLOGY
- Physiological roles of N-acetylglucosaminyltransferase V (GnT-V) in mice
- (2012) Eiji Miyoshi et al. BMB Reports
- Increased serum levels of soluble CD163 in patients with scleroderma
- (2012) Kazuhiro Shimizu et al. CLINICAL RHEUMATOLOGY
- Upregulation of N-acetylglucosaminyltransferase-V by heparin-binding EGF-like growth factor induces keratinocyte proliferation and epidermal hyperplasia
- (2012) Akihiro Kimura et al. EXPERIMENTAL DERMATOLOGY
- N-Acetylglucosaminyltransferase V regulates TGF-β response in hepatic stellate cells and the progression of steatohepatitis
- (2012) Yoshihiro Kamada et al. GLYCOBIOLOGY
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- The Immune Pathogenesis of Scleroderma: Context Is Everything
- (2012) Matthew B. Greenblatt et al. Current Rheumatology Reports
- Enhanced Epithelial-Mesenchymal Transition-like Phenotype inN-Acetylglucosaminyltransferase V Transgenic Mouse Skin Promotes Wound Healing
- (2011) Mika Terao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- N-Glycans Differentially Regulate Eosinophil and Neutrophil Recruitment during Allergic Airway Inflammation
- (2011) Nooshin S. Bahaie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis
- (2011) Haik Mkhikian et al. Nature Communications
- Alteration of Immune Responses by N-acetylglucosaminyltransferase V during Allergic Airway Inflammation
- (2011) Akiko Shibui et al. ALLERGOLOGY INTERNATIONAL
- Differential Roles of Macrophages in Diverse Phases of Skin Repair
- (2010) T. Lucas et al. JOURNAL OF IMMUNOLOGY
- MGAT5 alters the severity of multiple sclerosis
- (2010) B. Brynedal et al. JOURNAL OF NEUROIMMUNOLOGY
- MGAT5 and disease severity in progressive multiple sclerosis
- (2010) Federica Esposito et al. JOURNAL OF NEUROIMMUNOLOGY
- Serum levels of soluble CD163 in patients with systemic sclerosis
- (2010) Wakana Nakayama et al. RHEUMATOLOGY INTERNATIONAL
- Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis
- (2009) Patrizia Fuschiotti et al. ARTHRITIS AND RHEUMATISM
- Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma
- (2009) Nobuyo Higashi-Kuwata et al. EXPERIMENTAL DERMATOLOGY
- Tumor necrosis factor-α processing inhibitor-1 inhibits skin fibrosis in a bleomycin-induced murine model of scleroderma
- (2009) Mika Terao et al. EXPERIMENTAL DERMATOLOGY
- The Implication of N-Acetylglucosaminyl- transferase V Expression in Gastric Cancer
- (2008) Hai Tian et al. PATHOBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started